Enhanced Potency and Durability of Antibody Response to Seasonal Trivalent Inactivated Influenza Vaccine (TIV) Combined with a Novel Water-in-Oil Adjuvant System at Reduced Hemagglutinin (HA) Doses
نویسندگان
چکیده
1463. Enhanced Potency and Durability of Antibody Response to Seasonal Trivalent Inactivated Influenza Vaccine (TIV) Combined with a Novel Water-inOil Adjuvant System at Reduced Hemagglutinin (HA) Doses Geoffrey J. Gorse, MD, FIDSA; Stephen Grimes, PhD; Helen Buck, PhD; Hussain Mulla, PhD; Peter White, PhD; Irene Graham, MD; John J. Treanor, MD; Heather Hill, MS; Jeanine May, PhD and Peter Blackburn, PhD; VA St. Louis Health Care System, St. Louis, Missouri, Saint Louis University School of Medicine, St. Louis, Missouri, Mercia Pharma, Inc., New York, New York, Nova Immunotherapeutics Limited, Leicestershire, United Kingdom, Internal Medicine, Division of Infectious Diseases, Saint Louis University, Saint Louis, Missouri, Medicine, University of Rochester Medical Center School of Medicine and Dentistry, Rochester, New York, EMMES Corporation, Rockville, Maryland
منابع مشابه
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.
BACKGROUND Influenza-virus hemagglutinin (HA) protein expressed in insect cells by recombinant baculovirus is a candidate influenza vaccine. METHODS In a randomized, double-blind trial conducted in 399 adults > or = 65 years of age, the efficacy of trivalent inactivated influenza vaccine (TIV) licensed for intramuscular injection was compared with that of trivalent baculovirus-expressed HA va...
متن کاملA phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months
BACKGROUND There is a need for better vaccines and vaccine strategies to reduce the burden of influenza in very young children. METHODS This phase 1, open-label study assessed the reactogenicity, safety, and immunogenicity of an inactivated trivalent influenza vaccine (TIV) containing low doses of hemagglutinin antigen (7.5 µg each strain), adjuvanted with a tocopherol-based oil-in-water ...
متن کاملA randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine
BACKGROUND At the time of the influenza A(H1N1)pmd09 pandemic it was not known if concurrent or sequential administration of seasonal trivalent influenza vaccine (TIV) with pandemic vaccine was preferred. METHODS Immunogenicity and safety were assessed in 871 healthy subjects aged 19-40 years who were randomised into six groups to receive co-administration or sequential administration of TIV ...
متن کاملH3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination
BACKGROUND During the recent H1N1 influenza pandemic, excess morbidity and mortality was seen in young but not older adults suggesting that prior infection with influenza strains may have protected older subjects. In contrast, a history of recent seasonal trivalent vaccine in younger adults was not associated with protection. METHODS AND FINDINGS To study hemagglutinin (HA) antibody responses...
متن کاملSeasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant
Influenza epidemics occur annually, and estimated 5-10% of the adult population and 20-30% of children will become ill from influenza infection. Seasonal vaccines primarily work through the induction of neutralizing antibodies against the principal surface antigen hemagglutinin (HA). This important role of HA-specific antibodies explains why previous pandemics have emerged when new HAs have app...
متن کامل